Retirement Systems Of Alabama Incyte Corp Transaction History

Retirement Systems Of Alabama

$27.5 Billion
Q2 2025

A detailed history of Retirement Systems Of Alabama transactions in Incyte Corp stock. As of the latest transaction made, Retirement Systems Of Alabama holds 34,475 shares of INCY stock, worth $2.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,475

Previous 34,517 0.12%

Holding current value

$2.94 Million

Previous $2.09 Million 12.3%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	SELL	$55.17 - $71.22 $2,317 - $2,991	-42 Reduced 0.12%	34,475 $2.35 Million
Q1 2025 Apr 21, 2025	SELL	$60.0 - $75.26 $6,180 - $7,751	-103 Reduced 0.3%	34,517 $2.09 Million
Q4 2024 Jan 27, 2025	BUY	$65.08 - $83.38 $9,046 - $11,589	139 Added 0.4%	34,620 $2.39 Million
Q3 2024 Dec 06, 2024	SELL	$57.33 - $68.61 $142,350 - $170,358	-2,483 Reduced 6.72%	34,481 $2.28 Million
Q2 2024 Jul 24, 2024	SELL	$51.18 - $63.75 $209,377 - $260,801	-4,091 Reduced 9.96%	36,964 $2.24 Million
Q1 2024 Apr 30, 2024	BUY	$56.55 - $66.59 $3,449 - $4,061	61 Added 0.15%	41,055 $2.34 Million
Q4 2023 Feb 05, 2024	SELL	$52.16 - $64.19 $55,289 - $68,041	-1,060 Reduced 2.52%	40,994 $2.57 Million
Q3 2023 Nov 06, 2023	SELL	$57.77 - $65.93 $1,675 - $1,911	-29 Reduced 0.07%	42,054 $2.43 Million
Q2 2023 Jul 31, 2023	SELL	$60.95 - $75.51 $769,006 - $952,709	-12,617 Reduced 23.07%	42,083 $2.62 Million
Q1 2023 May 01, 2023	SELL	$70.23 - $86.01 $312,874 - $383,174	-4,455 Reduced 7.53%	54,700 $3.95 Million
Q4 2022 Feb 06, 2023	SELL	$67.18 - $84.11 $145,377 - $182,014	-2,164 Reduced 3.53%	59,155 $4.75 Million
Q3 2022 Nov 04, 2022	SELL	$66.18 - $82.86 $6.82 Million - $8.54 Million	-103,124 Reduced 62.71%	61,319 $4.09 Million
Q2 2022 Aug 03, 2022	SELL	$66.18 - $83.18 $1.35 Million - $1.7 Million	-20,407 Reduced 11.04%	164,443 $12.5 Million
Q1 2022 Apr 20, 2022	SELL	$66.02 - $79.71 $840,236 - $1.01 Million	-12,727 Reduced 6.44%	184,850 $14.7 Million
Q4 2021 Jan 20, 2022	BUY	$63.34 - $74.11 $945,222 - $1.11 Million	14,923 Added 8.17%	197,577 $14.5 Million
Q3 2021 Nov 03, 2021	BUY	$68.67 - $84.02 $1.04 Million - $1.27 Million	15,162 Added 9.05%	182,654 $12.6 Million
Q2 2021 Jul 21, 2021	BUY	$79.87 - $87.53 $204,067 - $223,639	2,555 Added 1.55%	167,492 $14.1 Million
Q1 2021 Apr 15, 2021	BUY	$76.02 - $100.5 $531,455 - $702,595	6,991 Added 4.43%	164,937 $13.4 Million
Q4 2020 Jan 26, 2021	BUY	$80.74 - $97.7 $1.25 Million - $1.52 Million	15,521 Added 10.9%	157,946 $13.7 Million
Q3 2020 Oct 20, 2020	BUY	$85.07 - $109.69 $5.55 Million - $7.16 Million	65,283 Added 84.63%	142,425 $12.8 Million
Q2 2020 Jul 23, 2020	SELL	$74.18 - $108.93 $107,412 - $157,730	-1,448 Reduced 1.84%	77,142 $8.02 Million
Q1 2020 Apr 20, 2020	BUY	$63.18 - $85.97 $1,137 - $1,547	18 Added 0.02%	78,590 $5.76 Million
Q4 2019 Jan 28, 2020	BUY	$73.04 - $95.72 $29,362 - $38,479	402 Added 0.51%	78,572 $6.86 Million
Q3 2019 Oct 30, 2019	SELL	$72.82 - $86.52 $352,084 - $418,324	-4,835 Reduced 5.82%	78,170 $5.8 Million
Q2 2019 Jul 09, 2019	BUY	$73.52 - $88.7 $20,512 - $24,747	279 Added 0.34%	83,005 $7.05 Million
Q1 2019 Apr 15, 2019	BUY	$63.56 - $88.17 $86,378 - $119,823	1,359 Added 1.67%	82,726 $7.12 Million
Q3 2018 Oct 24, 2018	SELL	$61.75 - $74.23 $60,576 - $72,819	-981 Reduced 1.19%	81,367 $5.62 Million
Q2 2018 Jul 17, 2018	SELL	$60.85 - $83.98 $9.16 Million - $12.6 Million	-150,478 Reduced 64.63%	82,348 $5.52 Million
Q1 2018 Apr 27, 2018	BUY	$83.06 - $100.98 $12.3 Million - $14.9 Million	147,941 Added 174.28%	232,826 $19.4 Million
Q4 2017 Feb 08, 2018	BUY	$93.56 - $116.6 $191,985 - $239,263	2,052 Added 2.48%	84,885 $8.04 Million
Q3 2017 Nov 06, 2017	BUY	$109.15 - $138.27 $9.04 Million - $11.5 Million	82,833	82,833 $9.67 Million

Others Institutions Holding INCY

# of Institutions

732

Shares Held

202M

Call Options Held

516K

Put Options Held

265K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $19B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Incyte Corp Transaction History